Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Brandman

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Transplantation|October 31, 2025
The Relentless Progression of Metabolic Dysfunction-associated Steatotic Liver Disease in Liver Transplantation in SpainLaura Martínez-Arenas, Ângela Carvalho-Gomes, Enrique Vidal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH ConsortiumMary E Rinella, Sanjaya K Satapathy, Danielle Brandman, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2022
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD)Danielle Brandman, Marie Boyle, Stuart McPherson, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2022
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' replyDanielle Brandman, Marie Boyle, Stuart McPherson, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Transplantation|October 31, 2025
The Relentless Progression of Metabolic Dysfunction-associated Steatotic Liver Disease in Liver Transplantation in SpainLaura Martínez-Arenas, Ângela Carvalho-Gomes, Enrique Vidal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH ConsortiumMary E Rinella, Sanjaya K Satapathy, Danielle Brandman, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2022
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD)Danielle Brandman, Marie Boyle, Stuart McPherson, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2022
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' replyDanielle Brandman, Marie Boyle, Stuart McPherson, et al.
Pageof 5